Trials / Conditions / Advanced Non-hematologic Malignancies
Advanced Non-hematologic Malignancies
4 registered clinical trials studyying Advanced Non-hematologic Malignancies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies NCT00948467 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Terminated | A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors NCT00915278 | Pfizer | Phase 1 |
| Completed | A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies NCT00830869 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies NCT01653158 | Pfizer | Phase 1 |